Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy
Conditions: Diabetic Foot; Diabetic Neuropathies; Diabetic Foot Ulcer Interventions: Biological: Transplantation of Placenta Derived Stem Cells Sponsors: Michael H Carstens; Ministerio de Salud de Nicaragua; Wake Forest Institute for Regenerative Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Pneumatic Reduction For Intussusception In Children: A Retrospective Cohort Study
Conditions: Intussusception Interventions: Procedure: Fluoroscopic-guided air-enema reduction (FGAR) Sponsors: National Children ' s Hospital, Vietnam; Vinmec Research Institute of Stem Cell and Gene Technology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
Conditions: B-NHL, Extranodal, TP53 Alterations, Bulky Mass Interventions: Biological: autologous stem-cell transplantation, Relmacabtagene autoleucel (relma-cel) Sponsors: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
Conditions: Acute Myocardial Infarction Interventions: Biological: Autologous Peripheral Blood Stem Cell injection Sponsors: Seoul National Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Varying Bone Marrow-Derived Mesenchymal Stem Cells Concentrations' Impact on Rotator Cuff Repair Outcomes
Conditions: Rotator Cuff Tears Interventions: Other: Rotator cuff repair augmented with whole bone marrow; Other: Rotator cuff repair augmented with concentrated bone marrow Sponsors: Johns Hopkins University; ON Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen
Conditions: CMV Infection or Reactivation After Allogenic HSCT Sponsors: Siriraj Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
Conditions: Low Back Pain Interventions: Biological: Lumbar Injections with 10cc ' s of Wharton ' s Jelly Allograft Sponsors: R3 Stem Cell; R3 Medical Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis; Secondary-Progressive Multiple Sclerosis; Mesenchymal Stem Cells Interventions: Biological: Allogenic placenta derived mesenchymal stem cells Sponsors: Tehran University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
MiSaver ® Stem Cell Treatment for Acute Myocardial Infarction
Conditions: Acute Myocardial Infarction Interventions: Drug: MiSaver Sponsors: Honya Medical Inc; Chung Shan Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
Conditions: Acute Lymphoblastic Leukaemia; Acute Leukemia of Ambiguous Lineage; Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Acute Myeloid Leukemia Interventions: Drug: EBX-102; Drug: Placebo Sponsors: Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
One Trocar-assisted Retroperitoneoscopic Ureteroureterostomy for Ureteral Duplication
Conditions: Ureteral Duplication Interventions: Procedure: one trocar-assisted retroperitoneoscopic ureteroureterostomy (OTAU) Sponsors: National Children ' s Hospital, Vietnam; Vinmec Research Institute of Stem Cell and Gene Technology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Minimally Invasive Surgical Management for Pediatric Intussusception: A Retrospective Cohort Study
Conditions: Intussusception Interventions: Procedure: Laparoscopic reduction; Procedure: Transumbilical mini-open reduction Sponsors: National Children ' s Hospital, Vietnam; Vinmec Research Institute of Stem Cell and Gene Technology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Comparative Health Status and Quality of Life of Patients With Sickle Cell Disease (SCD) Who Underwent Matched-sibling Hematopoietic Stem Cell Transplantation Versus Non Transplanted SCD Case-control Patients
Conditions: Sickle Cell Disease Interventions: Other: Spermogram; Other: Hospital Anxiety and Depression Scale (HADS); Other: SF36 Quality of life questionnaire; Other: Psychologist interview; Other: Optional sera banking; Other: Optional DNA banking Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS)
This study was approved by the Research Ethics Committees of Imam Khomeini Hospital Complex, Tehran University of Medical Science. Recruitment started in September 2022, with 20 patients randomized. The treatment follow-up of participants with tiotropium is currently ongoing and is due to finish in April 2024. The authors will disseminate the findings in peer-reviewed publications, conferences, and seminar presentations.Trial registrationIranian Registry of Clinical Trial (IRCT) IRCT20200415047080N3. Registered on 2022 –07-12, 1401/04/21. (Source: Trials)
Source: Trials - April 6, 2024 Category: Research Source Type: clinical trials
Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
Conditions: Glioblastoma; Glioma; Glioma Glioblastoma Multiforme Interventions: Other: cell isolation from tumor biopsies and biomarker investigation Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
